Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
pEYS606 in non-infectious uveitis
NCT03308045Phase 2Completed
- Sponsor
- Eyevensys
- Start
- Apr 2017
- Primary completion
- Jun 2021
- Modality
- Gene Editing, Gene Silencing, Plasmid DNA
- Countries
- 2
01
Overview
A Phase 2 trial of EYS606 in noninfectious uveitis (NIU), sponsored by Eyevensys. Started Apr 2017; status: completed.
02
Drugs
EYS606
03
Conditions
noninfectious uveitis (NIU)
Beyond the preview
Go deeper on NCT03308045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03308045.